Plunkett Research Online: BioCardia Inc

BIOCARDIA INC (BCDA:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

BioCardia Inc is a clinical-stage company developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases with significant unmet medical needs. Its two cell therapy platforms derived from the bone marrow.  CardiAMP® autologous mononuclear cell therapy pla.....



BioCardia Inc
Ticker: BCDA
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 310 987-7345
Fax:
Address: 320 Soquel Way
Sunnyvale, CA 94085 United States

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Surgical Appliance and Supplies Manufacturing
Contacts Description
Peter AltmanCEO/Director/President
David McClungCFO/Chief Accounting Officer
See More
BioCardia Inc is a clinical-stage company developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases with significant unmet medical needs. Its two cell therapy platforms derived from the bone marrow.  CardiAMP® autologous mononuclear cell therapy pla.....See More See More

Auditor: PKF Certified Public Accountants
Legal Advisor:
$USD, In whole numbers,
except marked * or %
202320222021202020192018
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and Affiliates Top Salaries
NameTitleSalary (US$)Bonus (US$)
Other Thoughts Corporate Culture

Apparent Female Officers or Directors: